The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dermatologic prophylaxis and impact on patient-reported outcomes in first-line EGFR-mutant advanced NSCLC treated with amivantamab plus lazertinib: Results from the phase 2 COCOON trial.
 
Jill Feldman
Honoraria - Mariana Oncology
Consulting or Advisory Role - AstraZeneca; Johnson & Johnson/Janssen; Troper Wojcicki Foundation/23&Me LCGS
Travel, Accommodations, Expenses - J&J; Mariana Oncology
 
Byoung Chul Cho
Employment - Yonsei University Health System
Leadership - J INTS BIO
Stock and Other Ownership Interests - Bridgebio; Cyrus therapeutics; Gencurix; Interpark Bio; J INTS BIO; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - Amgen; AnHeart Therapeutics; ArriVent Biopharma; AstraZeneca; BeiGene; BMS; Boehringer Ingelheim; Bridgebio; CJ bioscience; Cyrus therapeutics; Cyrus therapeutics; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Guardant Health; Harpoon Therapeutics; J INTS Bio; Janssen; Kanaph Therapeutics; Lilly; MSD; Novartis; Ono Pharmaceutical; Pfizer; Regeneron; Roche; Sanofi; Seagen; Takeda; Therapex Co., Ltd; Yuhan
Research Funding - AstraZeneca; Champions Oncology; CJ bioscience; Cyrus Therapeutics; Dong-A ST; GI Innovation; ImmuneOncia; J Ints Bio; Janssen; MSD; Therapex; Vertical Bio AG; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology; Crown Bioscience; Imagen; PearlRiver Bio GmbH
Other Relationship - DAAN Biotherapeutics
 
Weimin Li
No Relationships to Disclose
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; AMGEN; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Ipsen; Janssen; LEO Pharma; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); MSDavenir (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Janssen Oncology; Roche
 
Milena Mak
Honoraria - Bristol-Myers Squibb; Johnson & Johnson/Janssen; Lilly; Merck KGaA; Sanofi; United Medical
Travel, Accommodations, Expenses - Knight Pharmaceuticals
 
Maxwell Sauder
Stock and Other Ownership Interests - Johnson & Johnson; Merck
Honoraria - AbbVie; Amgen; Arcutis Biotherapeutics; Bausch Health; Bristol-Myers Squibb; Galderma; Incyte; Janssen; L'Oreal; Leo Pharma; Lilly; Merck; Novartis; Pfizer; Regeneron; Sanofi; Sun Pharma; UCB Canada
Consulting or Advisory Role - Abbvie; Amgen; Arcutis Biotherapeutics; Bausch Health; Bristol-Myers Squibb; Galderma, Inc.; Incyte; Janssen; L'Oreal; Leo Pharma; Lilly; Merck; Novartis; Pfizer; Regeneron; Sanofi; Sun Pharma; UCB Canada
Research Funding - Abbvie; Alumis; Amgen; Bristol-Myers Squibb; Galderma; Incyte; Janssen; Nektar; Pfizer; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Arcutis Biotherapeutics; Incyte; Johnson & Johnson; Pfizer
 
Farastuk Bozorgmehr
Honoraria - Abbvie; AstraZeneca; Daiichi Sankyo; GlaxoSmithKline; Janssen; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo; Janssen; Regeneron
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Jiunn-Liang Tan
Honoraria - AstraZeneca; MSD; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Johnson & Johnson
 
Jin-Yuan Shih
Honoraria - ABBVIE/ABBOTT; ACT Genomics; ACTgenomic; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; CStone Pharmaceuticals; Daiichi-Sankyo; GlaxoSmithKline,; Guardant Health; Illumina; Janssen; Lilly; Lotus; Merck KGaA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Orient EuroPharma; Pfizer; Roche; Synmosa Biopharma; Takeda; TSH Biopharm; TTY Biopharm; Welgene Biotech; Zuellig Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche; Takeda; Zuellig Pharma
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Pfizer; Roche
 
Danny Nguyen
Honoraria - Janssen Oncology; Taiho Pharmaceutical
Consulting or Advisory Role - Black Diamond Therapeutics; Janssen Oncology
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; Taiho Oncology
Other Relationship - Novartis; Pfizer; Seagen; Takeda
(OPTIONAL) Uncompensated Relationships - Johnson & Johnson/Janssen; Novartis; Takeda
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; ITeos Therapeutics; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; Daiichi Sankyo; Genentech; Gilead Sciences; Johnson & Johnson/Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; Novartis; Peervoice; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Roche
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; “Medical writing assistance for this abstract was provided by Nimisha H. Bhoola, PhD, of Nucleus Global, an Inizio Company, and funded by F. Hoffmann-La Roche Ltd.”; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023
 
Julia Schuchard
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Tonatiuh Romero
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Karen Xia
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Joshua Bauml
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Jairo Simoes
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Parthiv Mahadevia
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Mark Wildgust
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Alexander Spira
Leadership - Next Oncology (Inst)
Honoraria - Abbvie; Abbvie; Abbvie; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Janssen Oncology; Merck; Novartis; Prelude Therapeutics; Takeda
Consulting or Advisory Role - Amgen; ArriVent Biopharma; AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Black Diamond Therapeutics; Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca; Gritstone Bio; Gritstone Bio; incyte; Janssen Research & Development; Jazz Pharmaceuticals; Lilly; Merck (Inst); Mersana; Mirati Therapeutics; Novartis; Regeneron; Sanofi; Sanofi; Takeda
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); ADC Therapeutics (Inst); Alkermes (Inst); Amgen (Inst); ArriVent Biopharma (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); BluPrint Oncology (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Gritstone Bio (Inst); Ignyta (Inst); Incyte (Inst); Janssen Oncology (Inst); LAM Therapeutics; Loxo (Inst); Loxo (Inst); Macrogenics (Inst); Medikine (Inst); MedImmune (Inst); mersana (Inst); nalo therapeutics (Inst); Novartis (Inst); Plexxikon (Inst); Prelude Therapeutics (Inst); Regeneron (Inst); Revolution Medicines (Inst); Revolution Medicines (Inst); Roche (Inst); Rubius Therapeutics (Inst); Scorpion Therapeutics (Inst); Synthekine (Inst); Synthekine (Inst); Takeda (Inst)